Clinical Trial Update: Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

View source ↗

Summary

Completed clinical trial evaluating the impact of difficult-to-treat sites on biological response in moderate-to-severe plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Snippet

Sponsor: Pfizer | Conditions: Plaque Psoriasis | Status: COMPLETED | Results posted: 2021-10-25